XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 30,316 $ 98,668
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 13,077 12,406
Amortization of deferred debt issuance costs 4,107 4,256
Amortization 42,354 41,445
Stock-based compensation 23,352 19,336
Deferred income taxes 2,711 5,626
Non-cash adjustments to fair value of contingent consideration liability 3,504 (42,267)
Loss on early extinguishment of debt 363 0
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable 20,310 10,781
Inventories (15,242) (24,436)
Accounts payable 3,863 15,345
Accrued compensation and benefits 8,990 (8,063)
Other assets (12,934) (10,293)
Other liabilities (417) 826
Net cash provided by operating activities 124,354 123,630
Cash flows from investing activities:    
Purchases of property, plant and equipment (14,695) (9,044)
Other 850 0
Net cash used in investing activities (13,845) (9,044)
Cash flows from financing activities:    
Payments on term loan (79,821) 0
Proceeds from term loan 25,234 0
Payments on revolving line of credit (508,432) (567,000)
Proceeds from revolving line of credit 508,432 601,000
Payments to redeem convertible notes 0 (70,000)
Payments related to contingent consideration (22,577) (48,084)
Payments related to debt issuance costs (2,897) 0
Dividends paid on common stock (18,555) (18,474)
Other, net 166 2,628
Net cash used in financing activities (98,450) (99,930)
Effect of exchange rate changes on cash and cash equivalents 2,411 (485)
Net increase in cash and cash equivalents 14,470 14,171
Cash and cash equivalents at beginning of period 24,459 24,296
Cash and cash equivalents at end of period 38,929 38,467
Non-cash financing activities:    
Dividends payable $ 6,191 $ 6,178